They showed that 5-azacytidine treatment significantly increased expression of TET2 and TET3 in HCC cells, and TET2 knockdown disrupted the generation of 5-hmC by 5-azacytidine, suggesting that 5-azacytidine could trigger TET2-dependent active demethylation. Here, TET3 is linked to hepatocellular carcinoma.